Health
J&J says late-stage COVID-19 vaccine trial fully enrolled – Reuters
Johnson & Johnson said on Thursday it has fully enrolled participants for the first late-stage trial of its COVID-19 single-dose vaccine candidate.
By Reuters Staff
Dec 17 (Reuters) – Johnson & Johnson said on Thursday it has fully enrolled participants for the first late-stage trial of its COVID-19 single-dose vaccine candidate.
The study, named Ensemble, has enrolled about 45,000 participants and is being conducted by its unit Janssen, J&J said here in a statement, adding that it expects interim data from the trial by the end of January 2021.
J&J also said it plans to submit an emergency use authorization application to the U.S. Food and…
-
General24 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
General24 hours agoTariff letters to 12 countries going out Monday: Trump
-
Noosa News18 hours agoBrisbane’s original 1979 electric trains take one last journey
-
General23 hours agoNRL live updates: Canberra Raiders vs St George Illawarra Dragons, North Queensland Cowboys vs Melbourne Storm